GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NKX6-3
|
ENSG00000165066.11 | NK6 homeobox 3 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_125132803 | 3.58 |
ENST00000540753.1
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr3_-_141747950 | 3.30 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr9_+_125133315 | 1.92 |
ENST00000223423.4
ENST00000362012.2 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr8_-_90769422 | 1.88 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr4_+_80584903 | 1.83 |
ENST00000506460.1
|
RP11-452C8.1
|
RP11-452C8.1 |
chr3_-_141719195 | 1.70 |
ENST00000397991.4
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr13_+_53602894 | 1.52 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chr7_-_25268104 | 1.40 |
ENST00000222674.2
|
NPVF
|
neuropeptide VF precursor |
chr11_-_13517565 | 1.35 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chr14_-_51027838 | 1.29 |
ENST00000555216.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
chrX_+_107288239 | 1.02 |
ENST00000217957.5
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chrX_+_43515467 | 0.92 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chrX_+_107288197 | 0.82 |
ENST00000415430.3
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
chr19_+_50016610 | 0.76 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr15_+_93443419 | 0.75 |
ENST00000557381.1
ENST00000420239.2 |
CHD2
|
chromodomain helicase DNA binding protein 2 |
chr17_-_10372875 | 0.73 |
ENST00000255381.2
|
MYH4
|
myosin, heavy chain 4, skeletal muscle |
chr17_-_64225508 | 0.62 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr3_+_138340067 | 0.61 |
ENST00000479848.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
chr4_-_123542224 | 0.60 |
ENST00000264497.3
|
IL21
|
interleukin 21 |
chr5_-_142780280 | 0.58 |
ENST00000424646.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr19_+_4402659 | 0.53 |
ENST00000301280.5
ENST00000585854.1 |
CHAF1A
|
chromatin assembly factor 1, subunit A (p150) |
chr3_+_138340049 | 0.48 |
ENST00000464668.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
chr7_+_138145076 | 0.41 |
ENST00000343526.4
|
TRIM24
|
tripartite motif containing 24 |
chrX_-_130423200 | 0.37 |
ENST00000361420.3
|
IGSF1
|
immunoglobulin superfamily, member 1 |
chr8_+_77593448 | 0.37 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr8_+_77593474 | 0.34 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
chr6_+_114178512 | 0.31 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr5_-_58295712 | 0.26 |
ENST00000317118.8
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr16_-_67517716 | 0.23 |
ENST00000290953.2
|
AGRP
|
agouti related protein homolog (mouse) |
chr2_+_234826016 | 0.23 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr20_+_30697298 | 0.23 |
ENST00000398022.2
|
TM9SF4
|
transmembrane 9 superfamily protein member 4 |
chr3_+_121902511 | 0.22 |
ENST00000490131.1
|
CASR
|
calcium-sensing receptor |
chrX_+_47696275 | 0.22 |
ENST00000376954.1
ENST00000338637.7 |
ZNF81
|
zinc finger protein 81 |
chr5_-_139726181 | 0.21 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr1_-_151431647 | 0.21 |
ENST00000368863.2
ENST00000409503.1 ENST00000491586.1 ENST00000533351.1 ENST00000540984.1 |
POGZ
|
pogo transposable element with ZNF domain |
chr12_-_52761262 | 0.18 |
ENST00000257901.3
|
KRT85
|
keratin 85 |
chr20_-_33735070 | 0.15 |
ENST00000374491.3
ENST00000542871.1 ENST00000374492.3 |
EDEM2
|
ER degradation enhancer, mannosidase alpha-like 2 |
chr1_-_151431909 | 0.10 |
ENST00000361398.3
ENST00000271715.2 |
POGZ
|
pogo transposable element with ZNF domain |
chr11_+_22689648 | 0.07 |
ENST00000278187.3
|
GAS2
|
growth arrest-specific 2 |
chrX_-_110655306 | 0.05 |
ENST00000371993.2
|
DCX
|
doublecortin |
chr14_+_88851874 | 0.03 |
ENST00000393545.4
ENST00000356583.5 ENST00000555401.1 ENST00000553885.1 |
SPATA7
|
spermatogenesis associated 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:1900158 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.3 | 5.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 1.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 5.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.6 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 5.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 5.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 1.5 | GO:1904724 | specific granule lumen(GO:0035580) tertiary granule lumen(GO:1904724) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.6 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |